HOXB3 and myeloid sarcoma: Based on our proteomics and ELISA studies, we have recently identified that CSF level of homeobox protein Hox-B3 (HoxB3) may be used to predict conversion from clinically isolated syndrome to MS alone or in combination with YKL-40 [19,20].